Permanently Discontinued

PIPERACILLIN AND TAZOBACTAM FOR INJECTION

FRESENIUS KABI CANADA LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is PIPERACILLIN AND TAZOBACTAM FOR INJECTION discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that PIPERACILLIN AND TAZOBACTAM FOR INJECTION 4.5G 36G has been permanently discontinued (last updated August 20, 2024). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is PIPERACILLIN AND TAZOBACTAM FOR INJECTION not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength4.5G 36G

Last updated2024-08-20

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02465833

Strength

4.5G 36G

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

TAZOBACTAM PIPERACILLIN

Tier

Unrated

Last Updated

2024-08-20

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Other Products from FRESENIUS KABI CANADA LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION

900MG · DIN 02395150

2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION

20MG · DIN 02538644

5% DEXTROSE INJECTION

50MG · DIN 02403536

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02236926

ADDNUTRIV

DIN 02497697

ADENOSINE INJECTION

3MG · DIN 02457482